Syndromes of Thrombotic Microangiopathy
- PMID: 28189178
- DOI: 10.1016/j.mcna.2016.09.010
Syndromes of Thrombotic Microangiopathy
Abstract
Thrombotic thrombocytopenia purpura (TTP) and the hemolytic uremic syndrome (HUS) are rare thrombotic microangiopathies that can be rapidly fatal. Although the acquired versions of TTP and HUS are generally highest on this broad differential, multiple rarer entities can produce a clinical picture similar to TTP/HUS, including microangiopathic hemolysis, renal failure, and neurologic compromise. More recent analysis has discovered a host of genetic factors that can produce microangiopathic hemolytic syndromes. This article discusses the current understanding of thrombotic microangiopathy and outlines the pathophysiology and causative agents associated with each distinct syndrome as well as the most accepted treatments.
Keywords: Atypical hemolytic uremic syndrome (aHUS); Hemolytic uremic syndrome (HUS); Microangiopathic hemolytic anemia (MAHA); Pregnancy induced microangiopathic hemolytic anemia; Thrombotic thrombocytopenic purpura (TTP); Transplant induced microangiopathic hemolytic anemia.
Published by Elsevier Inc.
Similar articles
-
Pathology Consultation on the Diagnosis and Treatment of Thrombotic Microangiopathies (TMAs).Am J Clin Pathol. 2016 Feb;145(2):158-65. doi: 10.1093/ajcp/aqv086. Am J Clin Pathol. 2016. PMID: 27124904 Review.
-
Thrombotic microangiopathies: from animal models to human disease and cure.Contrib Nephrol. 2011;169:337-350. doi: 10.1159/000314579. Epub 2011 Jan 20. Contrib Nephrol. 2011. PMID: 21252531
-
Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: pathophysiology and management.Nephrol Nurs J. 2002 Apr;29(2):171-80; quiz 181-2. Nephrol Nurs J. 2002. PMID: 11997952 Review.
-
Thrombotic microangiopathies (TTP, HUS, HELLP).Emerg Med Clin North Am. 2014 Aug;32(3):649-71. doi: 10.1016/j.emc.2014.04.008. Epub 2014 Jun 3. Emerg Med Clin North Am. 2014. PMID: 25060255 Review.
-
Pathophysiology and management of thrombotic microangiopathies.J Nephrol. 1998 Nov-Dec;11(6):300-10. J Nephrol. 1998. PMID: 10048496 Review.
Cited by
-
Expert statement on the ICU management of patients with thrombotic thrombocytopenic purpura.Intensive Care Med. 2019 Nov;45(11):1518-1539. doi: 10.1007/s00134-019-05736-5. Epub 2019 Oct 7. Intensive Care Med. 2019. PMID: 31588978
-
When to consider targeted therapies in thrombotic microangiopathies in the modern era: walking the tightrope between cost, safety, and efficacy.J Thromb Thrombolysis. 2020 May;49(4):602-605. doi: 10.1007/s11239-020-02094-8. J Thromb Thrombolysis. 2020. PMID: 32219721 Free PMC article.
-
Urinary exosomes: a promising biomarker of drug-induced nephrotoxicity.Front Med (Lausanne). 2023 Sep 22;10:1251839. doi: 10.3389/fmed.2023.1251839. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37809338 Free PMC article. Review.
-
Influenza-associated thrombotic microangiopathies.Pediatr Nephrol. 2018 Nov;33(11):2009-2025. doi: 10.1007/s00467-017-3783-4. Epub 2017 Sep 7. Pediatr Nephrol. 2018. PMID: 28884355 Free PMC article. Review.
-
Spectrum of acute kidney injury associated with cocaine use: report of three cases.BMC Nephrol. 2019 Mar 20;20(1):99. doi: 10.1186/s12882-019-1279-0. BMC Nephrol. 2019. PMID: 30894132 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources